HBV genotypes and drug resistance mutations in antiretroviral treatment-naïve and treatment-experienced HBV-HIV co-infected patients

BACKGROUND: The presence of hepatitis B virus (HBV) resistance mutations upon initiation or during antiretroviral therapy (ART) in HIV co-infected patients is an important determinant of treatment response. The main objective of the study was to determine the prevalence of HBV resistance mutations i...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Antivir Ther
Main Authors: Archampong, Timothy N. A., Boyce, Ceejay L., Lartey, Margaret, Sagoe, Kwamena W., Obo-Akwa, Adjoa, Kenu, Ernest, Blackard, Jason T., Kwara, Awewura
Formato: Artigo
Idioma:Inglês
Publicado: 2016
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5106338/
https://ncbi.nlm.nih.gov/pubmed/27167598
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3851/IMP3055
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares